A Prospective, Single arm, Open label, Single centre clinical study to evaluate the safety and efficacy of Divyaratan oil in reducing headache, mental tension and fatigue. - NI

Aryanveda Cosmeceuticals0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1. Subjects aged between 18 to 65 years.
•2. Subjects suffering from mild to moderate anxiety (who achieve scores between 18 and 24
•points on the Hamilton Scale for Anxiety).
•3. Subjects of female gender or a non-pregnant, non-lactating female, at least six weeks
•postpartum. A urine pregnancy test is required for all female subjects unless the subject has
•had a hysterectomy or tubal ligation, or is > 2 years postmenopausal.
•4. Subjects are willing to follow the procedures as per the study protocol and voluntarily sign
•an informed consent form.

•1. Subjects having addiction to any drug, including alcohol will not be recruited in the trial.
•2. Subjects who are using any medication such as anxiolytic, anti-stress medication and
•under psychotherapy will not be recruited in the trial.
•3. Subjects having a chronic, contagious infectious disease, such as active tuberculosis,
•Hepatitis B or C, or HIV.
•4. Known hypersensitivity to ingredients used in the Investigational Product.
•5. Pregnant and Lactating females.

发起方

Aryanveda Cosmeceuticals